Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk

Stephanie Wo, Hannah Levavi, John Mascarenhas, Marina Kremyanskaya, Shyamala Navada, Michal Bar-Natan, Sara S. Kim

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk'. Together they form a unique fingerprint.

Medicine & Life Sciences